ISIN | LU1600334798 |
---|---|
Valor Number | 36465638 |
Bloomberg Global ID | UIMF GR |
Fund Name | UBS (Lux) Fund Solutions - MSCI Europe UCITS ETF (hedged to EUR) A-acc |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) |
UBS AG Basel Phone: +41 61 288 20 20 UBS AG, Zürich Zürich Phone: +41 44 234 11 11 |
Asset Class | Equities |
EFC Category | Equity Advanced Europe |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The sub-fund aims to track, before expenses, the price and income performance of the MSCI Europe Index (Net Return) (this sub-fund's "Index"). |
Peculiarities |
Current Price * | 16.14 EUR | 03.04.2025 |
---|---|---|
Previous Price * | 16.55 EUR | 02.04.2025 |
52 Week High * | 17.25 EUR | 03.03.2025 |
52 Week Low * | 14.94 EUR | 05.08.2024 |
NAV * | 16.14 EUR | 03.04.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 484,364,885 | |
Unit/Share Assets *** | 66,614,812 | |
Trading Information SIX |
YTD Performance | +4.18% |
31.12.2024 - 03.04.2025
31.12.2024 03.04.2025 |
---|---|---|
YTD Performance (in CHF) | +5.16% |
31.12.2024 - 03.04.2025
31.12.2024 03.04.2025 |
1 month | -6.44% |
03.03.2025 - 03.04.2025
03.03.2025 03.04.2025 |
3 months | +3.98% |
03.01.2025 - 03.04.2025
03.01.2025 03.04.2025 |
6 months | +2.21% |
03.10.2024 - 03.04.2025
03.10.2024 03.04.2025 |
1 year | +4.33% |
03.04.2024 - 03.04.2025
03.04.2024 03.04.2025 |
2 years | +18.66% |
03.04.2023 - 03.04.2025
03.04.2023 03.04.2025 |
3 years | +23.13% |
04.04.2022 - 03.04.2025
04.04.2022 03.04.2025 |
5 years | +86.82% |
03.04.2020 - 03.04.2025
03.04.2020 03.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
SAP SE | 2.47% | |
---|---|---|
Nestle SA | 2.33% | |
ASML Holding NV | 2.30% | |
Roche Holding AG | 2.03% | |
AstraZeneca PLC | 1.98% | |
Novo Nordisk AS Class B | 1.95% | |
Shell PLC | 1.92% | |
Novartis AG Registered Shares | 1.92% | |
HSBC Holdings PLC | 1.77% | |
Siemens AG | 1.54% | |
Last data update | 01.04.2025 |
TER | 0.13% |
---|---|
TER date | 30.06.2024 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.13% |
Ongoing Charges *** | 0.13% |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |